{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(1)"],"submitter":["de Oliveira FL"],"pubmed_abstract":["Galectin-3 (Gal-3) is a β-galactoside binding protein that controls cell-cell and cell-extracellular matrix interactions. In lymphoid organs, gal-3 inhibits B cell differentiation by mechanisms poorly understood. The B cell development is dependent on tissue organization and stromal cell signaling, including IL-7 and Notch pathways. Here, we investigate possible mechanisms that gal-3 interferes during B lymphocyte differentiation in the bone marrow (BM) and spleen. The BM of gal-3-deficient mice (Lgals3<sup>-/-</sup> mice) was evidenced by elevated numbers of B220<sup>+</sup>CD19<sup>+</sup>c-Kit<sup>+</sup>IL-7R<sup>+</sup> progenitor B cells. In parallel, CD45<sup>-</sup> bone marrow stromal cells expressed high levels of mRNA IL-7, Notch ligands (Jagged-1 and Delta-like 4), and transcription factors (Hes-1, Hey-1, Hey-2 and Hey-L). The spleen of Lgals3<sup>-/-</sup> mice was hallmarked by marginal zone disorganization, high number of IgM<sup>+</sup>IgD<sup>+</sup> B cells and CD138<sup>+</sup> plasma cells, overexpression of Notch ligands (Jagged-1, Delta-like 1 and Delta-like 4) by stromal cells and Hey-1. Morever, IgM<sup>+</sup>IgD<sup>+</sup> B cells and B220<sup>+</sup>CD138<sup>+</sup> CXCR4<sup>+</sup> plasmablasts were significantly increased in the BM and blood of Lgals3<sup>-/-</sup> mice. For the first time, we demonstrated that gal-3 inhibits Notch signaling activation in lymphoid organs regulating earlier and terminal events of B cell differentiation."],"journal":["Scientific reports"],"pagination":["3495"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5823902"],"repository":["biostudies-literature"],"pubmed_title":["Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiation."],"pmcid":["PMC5823902"],"pubmed_authors":["Pereira JX","Fermino ML","de Oliveira FL","Ricon L","Brand C","El-Cheikh MC","Bernardes ES","Dos Santos SN","da Costa TP","Chammas R"],"additional_accession":[]},"is_claimable":false,"name":"Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiation.","description":"Galectin-3 (Gal-3) is a β-galactoside binding protein that controls cell-cell and cell-extracellular matrix interactions. In lymphoid organs, gal-3 inhibits B cell differentiation by mechanisms poorly understood. The B cell development is dependent on tissue organization and stromal cell signaling, including IL-7 and Notch pathways. Here, we investigate possible mechanisms that gal-3 interferes during B lymphocyte differentiation in the bone marrow (BM) and spleen. The BM of gal-3-deficient mice (Lgals3<sup>-/-</sup> mice) was evidenced by elevated numbers of B220<sup>+</sup>CD19<sup>+</sup>c-Kit<sup>+</sup>IL-7R<sup>+</sup> progenitor B cells. In parallel, CD45<sup>-</sup> bone marrow stromal cells expressed high levels of mRNA IL-7, Notch ligands (Jagged-1 and Delta-like 4), and transcription factors (Hes-1, Hey-1, Hey-2 and Hey-L). The spleen of Lgals3<sup>-/-</sup> mice was hallmarked by marginal zone disorganization, high number of IgM<sup>+</sup>IgD<sup>+</sup> B cells and CD138<sup>+</sup> plasma cells, overexpression of Notch ligands (Jagged-1, Delta-like 1 and Delta-like 4) by stromal cells and Hey-1. Morever, IgM<sup>+</sup>IgD<sup>+</sup> B cells and B220<sup>+</sup>CD138<sup>+</sup> CXCR4<sup>+</sup> plasmablasts were significantly increased in the BM and blood of Lgals3<sup>-/-</sup> mice. For the first time, we demonstrated that gal-3 inhibits Notch signaling activation in lymphoid organs regulating earlier and terminal events of B cell differentiation.","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Feb","modification":"2024-11-10T04:17:52.849Z","creation":"2019-03-26T23:04:01Z"},"accession":"S-EPMC5823902","cross_references":{"pubmed":["29472568"],"doi":["10.1038/s41598-018-21409-7"]}}